WELCOME TO The chemical REPORT
Newsletter | Member Login | Signup
Home > Companies > Berryman Chemical Inc
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
Chemical Management
Businesswire | April 27, 2023
NatureWorks, leading manufacturer of polylactic acid (PLA) biopolymers, announces, in collaboration with Jabil Inc., a global manufacturing solutions provider, the availability of an Ingeo™ PLA-based powder formulation for powder-bed fusion technologies, including selective laser sintering (SLS) printer platforms. The new product marketed as Jabil PLA 3110P, offers a cost-effective option, with lower sintering temperature, and 89% smaller carbon footprint1 compared to the incumbent P...
Products and Technologies
Westlake | November 25, 2021
Westlake Chemical Corporation, announced that it has entered into a definitive agreement with Hexion Inc. to acquire Hexion’s global epoxy business for approximately $1.2 billion. Based in Rotterdam, The Netherlands, Hexion’s epoxy business is an industry leader in the manufacture and development of specialty resins, coatings and composites for a variety of industries, including high-growth and sustainability-oriented end-uses such as wind turbine blades and light-weight automotive s...
Raytheon Technologies | July 20, 2022
Raytheon Technologies has been selected by the U.S. Department of Energy for two research and development projects to test the use of hydrogen and ammonia as effective, zero-carbon options for electricity generation. "These projects are the latest examples of how we're partnering with the Department of Energy to innovate the technologies that will power a cleaner, more sustainable future," said Andreas Roelofs, director of the Raytheon Technology Research Center, the...
Baylor College of Medicine | July 10, 2020
Scientists at Baylor College of Medicine have devised a chemical approach for discovering new enzyme-binding compounds that could be developed into drugs for various illnesses and conditions. This process can be used to support development of novel antiviral drugs for use in the continuing COVID-19 pandemic. The study, published online today in the Proceedings of the National Academy of Sciences USA, was co-led by Dr. Surendra Dawadi, instructor in the Center for Drug Discovery at...
Whitepaper
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE